ALLEGAN -- Perrigo Co. (Nasdaq: PRGO) announced that it has received final approval from the United States Food and Drug Administration for its abbreviated new drug application for calcium acetate ...
Perrigo announced that it has received final approval from the FDA for its abbreviated new drug application for calcium acetate capsules, the generic equivalent of Phoslo Gelcaps. Perrigo was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback